Singapore markets closed
Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,032.51 +14.12 (+0.28%) Dow
38,047.35 +144.06 (+0.38%) Nasdaq
15,696.71 +91.22 (+0.58%) Bitcoin USD
59,035.57 +1,666.97 (+2.91%) CMC Crypto 200
1,270.73 -0.01 (-0.00%)
IDEAYA Biosciences, Inc. (30J.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:31AM CEST. Market open.
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 2.84B |
| Enterprise value | 2.35B |
| Trailing P/E | N/A |
| Forward P/E | 9.49 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 98.57 |
| Price/book (mrq) | 4.82 |
| Enterprise value/revenue | 100.45 |
| Enterprise value/EBITDA | -18.01 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.80 |
| 52-week change 3 | 117.44% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 44.40 |
| 52-week low 3 | 16.90 |
| 50-day moving average 3 | 39.20 |
| 200-day moving average 3 | 31.22 |
Share statistics
| Avg vol (3-month) 3 | 19 |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 74.76M |
| Implied shares outstanding 6 | 77.18M |
| Float 8 | 73.72M |
| % held by insiders 1 | 0.98% |
| % held by institutions 1 | 104.24% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -1,068.77% |
Management effectiveness
| Return on assets (ttm) | -16.20% |
| Return on equity (ttm) | -23.28% |
Income statement
| Revenue (ttm) | 23.39M |
| Revenue per share (ttm) | 0.41 |
| Quarterly revenue growth (yoy) | -2.50% |
| Gross profit (ttm) | N/A |
| EBITDA | -131.95M |
| Net income avi to common (ttm) | -112.96M |
| Diluted EPS (ttm) | -1.83 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 525.11M |
| Total cash per share (mrq) | 7.04 |
| Total debt (mrq) | 2.87M |
| Total debt/equity (mrq) | 0.46% |
| Current ratio (mrq) | 19.65 |
| Book value per share (mrq) | 9.55 |
Cash flow statement
| Operating cash flow (ttm) | -115.22M |
| Levered free cash flow (ttm) | -70.28M |
© 2024 Yahoo. All rights reserved.